Form 8-K - Current report:
SEC Accession No. 0000885590-22-000013
Filing Date
2022-03-14
Accepted
2022-03-14 06:40:52
Documents
12
Period of Report
2022-03-14
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20220314.htm   iXBRL 8-K 33614
  Complete submission text file 0000885590-22-000013.txt   173626

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20220314.xsd EX-101.SCH 1920
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20220314_lab.xml EX-101.LAB 25096
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20220314_pre.xml EX-101.PRE 13047
6 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20220314_htm.xml XML 11466
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22735029
SIC: 2834 Pharmaceutical Preparations